$2.48
0.06952.88%
最終更新: Nov 6, 6:48 PM

The average analyst price target for Biodexa Pharmaceuticals is $80,000, 3265206.1% above the current price. The one analyst covering it rates it Buy. The latest change came on Feb 8, 2024, when Ladenburg Thalmann initiated coverage of Biodexa Pharmaceuticals with a Buy rating and a $80,000 price target.
Price Target Range — 1 Quarters
Analyst Consensus — 1 Analysts
Rating Trend — Last 9 Months